Automate Data Collection

USE CASE

Say goodbye to pill counts and medication diaries.

Many trials continue to use paper diaries. eDiaries are an improvement, but have their own pitfalls. Our smart packaging is the modern solution for modern trials.

Not only do we automatically collect data, but we automate analysis of this data as well.

Solutions

Automatic Dose Tracking

We make blistered and bottled smart packaging that automatically records each dose. Dose data can viewed instantly (for real-time use cases), or stored on the smart package for up 3 years later (for retrospective use cases). All devices are manufactured in ISO/GMP compliant facilities.

Automatic Analysis

Each dose is classified and labeled as per your protocol: “Adherent”, “Early”, “Late”, “Extra”, and more. We identify trends at the participant, site, and study level. Data export is fast and on-demand. Web dashboards are available for study staff to monitor and review data. Staff can opt in, to be involved as they see fit. And a mobile app provides participants with informative screens and self-motivation features.

Reconciliation

Final pill counts and drug accountability are automated: our smart packages know which doses were taken and which were not. For rare cases where digital data disagrees with the real world remaining doses or intake times, there are options to edit the dose history in ways that preserve the original records and ensure auditable traceability.

Specific Benefits

Objective, Precise Data

The sensors in our smart packaging can take accurate readings every minute. They have onboard storage for thousands of readings.

Passive, Background Operation

Our monitoring and alerting features work automatically without blocking trial procedures or adding new burdens or processes.

Reduced Participant Burden

Smart packaging requires less participant effort than paper diaries or eDiaries, and is more accurate and objective.

Reduced Site Burden

Data acquisition is automatic and always accurate. There is no need to worry about transcription errors or paper documentation.

Lasts as Long as the Trial

All smart packages are designed to operate for 3+ years. Meaning that they will continue providing data regardless of trial duration, or trial delays, or other unforeseen events.

Learn More about the Products
that Power our Solutions

Med-ic®

The original smart blister package. Breaking a blister records the time and location (i.e. “8:00 a.m.” and “Day 1, Morning”). Med-ic can be customized to work with any blister design and dose pattern.

eCap™

The superior smart cap. Unscrewing and removing the eCap records the opening time. Several diameter and threading options are available to fit all common bottle types.

CertiScan® Platform

Consumer-quality software for clinical trials. Securely store, analyze, and action the data from smart packaging and other adherence devices. The CertiScan Platform includes web portals, mobile apps, developer tools, and a secure, central cloud.

Did You Know?

Traditional drug diaries and pill counts are error prone, tedious, and not conducive to remote or decentralized trials. Many are completed retrospectively, with poor recollection on the participant’s part. CertiScan unit-dose tracking, reminders, and coaching are automated, mobile-first, precise, and do not burden patients or staff.

The FDA, through its Critical Path initiative, has expressed an interest in the application of new tools to clinical trials. Automated data collection and medication adherence monitoring can be an integral part of this process.

ROI

Our experts have modelled the relationship between statistical power, sample size and medication adherence.

Their findings? For every 1% adherence increase, there can be a 2% reduction in trial size (N) while holding statistical power constant.

Considering that many trials currently only reach 50% adherence, there’s lots of room for improvement – and tremendous ROI.

Direct Savings from Reduced N

Processing a participant is expensive. Requiring a smaller sample size could amount to millions of dollars in savings.

Additional Weeks of Patent Protection

Smaller N means a faster trial, potentially by months. This could amount to tens of millions of dollars in additional revenue.

Additional Weeks of Patent Protection

Smaller N means a faster trial, potentially by months. This could amount to tens of millions of dollars in additional revenue.

Recent Articles

Press Releases | 6 May 2024

Information Mediary Corp. and…

PRESS RELEASE May 6, 2024 – New York, NY — Information Mediary Corp (IMC)…

Blog | 5 May 2024

Welcome to the new…

We are thrilled to unveil our revamped website! As you explore our new digital…

Case Study | 5 May 2024

Evaluating Hepatitis C Treatment…

Overview Direct-Acting Antiviral (DAA) therapy is an effective treatment for hepatitis C. However DAA…

Scientific Publication | 5 May 2024

Independent Study finds eCAP…

Whitepapers | 5 May 2024

Driving Adherence With Smart…

Press Releases | 4 May 2024

IMC introduces CertiScan® 2.0

Att: Health Tech Desk FOR IMMEDIATE RELEASE April 28, 2021 New York, NY Contact:…

Let's Talk

Our mission is to create adherence-focused technologies that enable safer, faster, more efficient, and more innovative clinical research. There’s an IMC solution that will transform your next trial. Don’t wait, start the conversation with our team now. We’ll reach out in order to:

Deeply understand your particular needs.
Explore how Med-ic, eCap, and CertiScan, can benefit your study.
Work collaboratively to prepare a specific solution that will exceed your expectations.

Connect with Us

By clicking "Submit" you agree to our Privacy Policy

Book a Demo

Contact Sales